Retrospective Study
Copyright ©The Author(s) 2022.
World J Radiol. Sep 28, 2022; 14(9): 319-328
Published online Sep 28, 2022. doi: 10.4329/wjr.v14.i9.319
Table 1 Sensitivity, specificity, positive predictive value and negative predictive value per ovarian-adnexal reporting and data system category for each reader on the pre-training assessment
Pre training
ORADS 1, %
ORADS 2, %
ORADS 3, %
ORADS 4, %
ORADS 5, %
Sensitivity
R190 (55.5 to 99.8)100 (69.5 to 100)100 (59.0 to 100)92 (61.5 to 99.8)55 (23.4 to 83.3)
R290% (55.5 to 99.8)100% (69.2 to 100)71 (29.0 to 96.3)92 (61.5 to 99.8)82 (48.2 to 97.7)
R390 (55.5 to 99.8)100 (69.2 to 100)100 (59.0 to 100)75 (42.8 to 94.5) 55 (23.4 to 83.3)
Specificity
R1100 (91.2 to 100)85 (70.2 to 94.3)98 (87.7 to 99.4)100 (90.8 to 100)100 (91.0 to 100)
R2100 (91.2 to 100)90 (76.3 to 97.2)98 (87.7 to 99.4)97 (86.2 to 99.9)100 (91.0 to 100)
R398 (86.8 to 99.9)90 (76.3 to 97.2)95 (84.2 to 99.4)95 (82.3 to 99.4)100 (91.0 to 100)
PPV
R110063 (44.4 to 77.7)88 (50.2 to 98.0)100100
R210071 (49.7 to 86.4)83 (40.5 to 97.4)92 (61.2 to 98.7)100
R390 (56.2 to 98.4)71 (49.7 to 86.4)78 (47.5 to 93.1)82 (52.9 to 94.8)100
NPV
R198 (86.2 to 99.6)10010097 (85.3 to 99.6)89 (80.3 to 93.7)
R298 (86.2 to 99.6)10096 (86.7 to 98.6)97 (85.0 to 99.6)95 (84.8 to 98.6)
R398 (85.9 to 99.6)10010093 (81.8 to 97.0)89 (80.3 to 93.7)